Chinese Journal of Chromatography ›› 2022, Vol. 40 ›› Issue (9): 843-853.DOI: 10.3724/SP.J.1123.2021.12028
• Technical Notes • Previous Articles Next Articles
FENG Junjun1, JIANG Haiyun2, WANG Jing3, JING Zhengyi1, ZHANG Fan1, TAN Tianyu1, HE Feng1, JIANG Lihua1, LI Haiqin1, CHANG Shimin1, LI Tengfei1,*()
Received:
2021-12-28
Online:
2022-09-08
Published:
2022-09-26
Contact:
LI Tengfei
Supported by:
CLC Number:
FENG Junjun, JIANG Haiyun, WANG Jing, JING Zhengyi, ZHANG Fan, TAN Tianyu, HE Feng, JIANG Lihua, LI Haiqin, CHANG Shimin, LI Tengfei. Simultaneous determination of 40 plant growth regulators, fungicides, insecticides, and antibiotics in bean sprouts by QuEChERS-high performance liquid chromatography-tandem mass spectrometry[J]. Chinese Journal of Chromatography, 2022, 40(9): 843-853.
No. | Compound | Retention time/min | Ionization mode | Precursor ion (m/z) | Product ions (m/z) | Collision energies/eV |
---|---|---|---|---|---|---|
1 | chlormequat (矮壮素) | 1.066 | ESI+ | 122.10 | 58.10*, 63.10 | -31, -24 |
2 | ronidazole (洛硝哒唑) | 3.903 | ESI+ | 201.00 | 139.70*, 54.60 | -10, -15 |
3 | metronidazole (甲硝唑) | 3.999 | ESI+ | 172.00 | 81.80*, 127.70 | -25, -15 |
4 | pymetrozine (吡蚜酮) | 4.192 | ESI+ | 408.10 | 105.05*, 68.10 | -39, -30 |
5 | dimetridazole (二甲硝咪唑) | 5.211 | ESI+ | 142.10 | 96.05*, 81.10 | -16, -27 |
6 | methomyl (灭多威) | 6.850 | ESI+ | 163.05 | 88.00*, 106.05 | -11, -13 |
7 | carbendazim (多菌灵) | 6.959 | ESI+ | 192.05 | 160.05*, 32.05 | -17, -30 |
8 | levofloxacin (氧氟沙星) | 7.261 | ESI+ | 362.10 | 318.20*, 61.10 | -20, -30 |
9 | enoxacin (依诺沙星) | 7.272 | ESI+ | 340.20 | 303.10*, 203.85 | -20, -48 |
10 | pefloxacin mesylate (培氟沙星) | 7.301 | ESI+ | 334.00 | 290.10*, 16.10 | -20, -20 |
11 | norfloxacin (诺氟沙星) | 7.384 | ESI+ | 320.00 | 302.00*, 76.00 | -20, -17 |
12 | ciprofloxacin (环丙沙星) | 7.537 | ESI+ | 332.20 | 314.05*, 31.00 | -24, -41 |
13 | enrofloxacin (恩诺沙星) | 7.672 | ESI+ | 360.20 | 316.10*, 42.15 | -22, -25 |
14 | thiabendazole (噻菌灵) | 7.749 | ESI+ | 202.00 | 175.05*, 31.10 | -24, -33 |
15 | lomefloxacin (洛美沙星) | 7.749 | ESI+ | 352.00 | 265.00*, 80.10 | -25, -20 |
16 | chlorpyrifos (毒死蜱) | 7.768 | ESI+ | 351.90 | 265.05*, 37.05 | -30, -39 |
17 | sarafloxacin (沙拉沙星) | 8.048 | ESI+ | 385.90 | 367.95*, 98.90 | -25, -20 |
18 | imidacloprid (吡虫啉) | 8.172 | ESI+ | 256.05 | 175.10*, 09.05 | -17, -14 |
19 | sparfloxacin (司帕沙星) | 8.480 | ESI+ | 393.00 | 349.00*, 92.00 | -40, -20 |
20 | acetamiprid (啶虫脒) | 8.682 | ESI+ | 223.10 | 126.05*, 56.05 | -22, -15 |
21 | gibberellic acid (赤霉素) | 8.744 | ESI- | 345.40 | 143.20*, 39.50 | 32, 16 |
22 | 4-fluorophenoxyacetic acid (4-氟苯氧乙酸) | 8.941 | ESI- | 169.20 | 111.00*, 95.00 | 16, 18 |
23 | chloramphenicol (氯霉素) | 9.144 | ESI- | 340.00 | 152.10*, 57.10 | 17, 11 |
24 | 3-indolylacetic acid (吲哚乙酸) | 9.230 | ESI+ | 176.10 | 129.80*, 03.10 | -18, -16 |
25 | N6-(δ2-isopentenyl)-adenine (异戊烯腺嘌呤) | 9.434 | ESI- | 202.30 | 133.00*, 34.15 | 22, 17 |
26 | 6-benzylaminopurine (6-苄基腺嘌呤) | 9.487 | ESI- | 224.00 | 133.00*, 06.00 | 40, 34 |
27 | 4-chlorophenoxyacetic acid (4-氯苯氧乙酸) | 10.040 | ESI- | 185.00 | 127.10*, 29.00 | 15, 14 |
28 | thidiazuron (噻苯隆) | 10.056 | ESI+ | 240.20 | 102.00*, 28.00 | -16, -17 |
29 | 3-indolebutyric acid (吲哚丁酸) | 10.229 | ESI+ | 204.20 | 186.20*, 29.90 | -10, -28 |
30 | atrazine (莠去津) | 10.556 | ESI+ | 406.10 | 174.05*, 96.05 | -17, -25 |
31 | forchlorfenuron (氯吡脲) | 10.595 | ESI+ | 248.05 | 129.05*, 93.05 | -17, -34 |
32 | metalaxyl-M (精甲霜灵) | 10.614 | ESI+ | 280.10 | 220.15*, 48.10 | -13, -10 |
33 | metalaxyl (甲霜灵) | 10.619 | ESI+ | 280.10 | 220.15*, 92.15 | -13, -18 |
34 | 2,4-dichlorophenoxyacetic acid (2,4-滴) | 10.669 | ESI- | 409.00 | 160.85*, 25.00 | 14, 29 |
35 | azoxystrobin (嘧菌酯) | 10.826 | ESI+ | 404.10 | 372.05*, 29.00 | -14, -31 |
36 | paclobutrazol (多效唑) | 11.064 | ESI+ | 294.10 | 70.05*, 125.05 | -40, -40 |
37 | triazophos (三唑磷) | 11.152 | ESI+ | 314.05 | 162.15*, 19.15 | -19, -35 |
38 | isazophos (氯唑磷) | 11.161 | ESI+ | 314.10 | 162.10*, 20.10 | -16, -27 |
39 | flusilazole (氟硅唑) | 11.394 | ESI+ | 316.10 | 247.10*, 65.10 | -18, -29 |
40 | pyraclostrobin (吡唑醚菌酯) | 11.635 | ESI+ | 388.10 | 194.05*, 63.05 | -30, -32 |
Table 1 Retention times and MS/MS parameters for the 40 compounds in MRM mode
No. | Compound | Retention time/min | Ionization mode | Precursor ion (m/z) | Product ions (m/z) | Collision energies/eV |
---|---|---|---|---|---|---|
1 | chlormequat (矮壮素) | 1.066 | ESI+ | 122.10 | 58.10*, 63.10 | -31, -24 |
2 | ronidazole (洛硝哒唑) | 3.903 | ESI+ | 201.00 | 139.70*, 54.60 | -10, -15 |
3 | metronidazole (甲硝唑) | 3.999 | ESI+ | 172.00 | 81.80*, 127.70 | -25, -15 |
4 | pymetrozine (吡蚜酮) | 4.192 | ESI+ | 408.10 | 105.05*, 68.10 | -39, -30 |
5 | dimetridazole (二甲硝咪唑) | 5.211 | ESI+ | 142.10 | 96.05*, 81.10 | -16, -27 |
6 | methomyl (灭多威) | 6.850 | ESI+ | 163.05 | 88.00*, 106.05 | -11, -13 |
7 | carbendazim (多菌灵) | 6.959 | ESI+ | 192.05 | 160.05*, 32.05 | -17, -30 |
8 | levofloxacin (氧氟沙星) | 7.261 | ESI+ | 362.10 | 318.20*, 61.10 | -20, -30 |
9 | enoxacin (依诺沙星) | 7.272 | ESI+ | 340.20 | 303.10*, 203.85 | -20, -48 |
10 | pefloxacin mesylate (培氟沙星) | 7.301 | ESI+ | 334.00 | 290.10*, 16.10 | -20, -20 |
11 | norfloxacin (诺氟沙星) | 7.384 | ESI+ | 320.00 | 302.00*, 76.00 | -20, -17 |
12 | ciprofloxacin (环丙沙星) | 7.537 | ESI+ | 332.20 | 314.05*, 31.00 | -24, -41 |
13 | enrofloxacin (恩诺沙星) | 7.672 | ESI+ | 360.20 | 316.10*, 42.15 | -22, -25 |
14 | thiabendazole (噻菌灵) | 7.749 | ESI+ | 202.00 | 175.05*, 31.10 | -24, -33 |
15 | lomefloxacin (洛美沙星) | 7.749 | ESI+ | 352.00 | 265.00*, 80.10 | -25, -20 |
16 | chlorpyrifos (毒死蜱) | 7.768 | ESI+ | 351.90 | 265.05*, 37.05 | -30, -39 |
17 | sarafloxacin (沙拉沙星) | 8.048 | ESI+ | 385.90 | 367.95*, 98.90 | -25, -20 |
18 | imidacloprid (吡虫啉) | 8.172 | ESI+ | 256.05 | 175.10*, 09.05 | -17, -14 |
19 | sparfloxacin (司帕沙星) | 8.480 | ESI+ | 393.00 | 349.00*, 92.00 | -40, -20 |
20 | acetamiprid (啶虫脒) | 8.682 | ESI+ | 223.10 | 126.05*, 56.05 | -22, -15 |
21 | gibberellic acid (赤霉素) | 8.744 | ESI- | 345.40 | 143.20*, 39.50 | 32, 16 |
22 | 4-fluorophenoxyacetic acid (4-氟苯氧乙酸) | 8.941 | ESI- | 169.20 | 111.00*, 95.00 | 16, 18 |
23 | chloramphenicol (氯霉素) | 9.144 | ESI- | 340.00 | 152.10*, 57.10 | 17, 11 |
24 | 3-indolylacetic acid (吲哚乙酸) | 9.230 | ESI+ | 176.10 | 129.80*, 03.10 | -18, -16 |
25 | N6-(δ2-isopentenyl)-adenine (异戊烯腺嘌呤) | 9.434 | ESI- | 202.30 | 133.00*, 34.15 | 22, 17 |
26 | 6-benzylaminopurine (6-苄基腺嘌呤) | 9.487 | ESI- | 224.00 | 133.00*, 06.00 | 40, 34 |
27 | 4-chlorophenoxyacetic acid (4-氯苯氧乙酸) | 10.040 | ESI- | 185.00 | 127.10*, 29.00 | 15, 14 |
28 | thidiazuron (噻苯隆) | 10.056 | ESI+ | 240.20 | 102.00*, 28.00 | -16, -17 |
29 | 3-indolebutyric acid (吲哚丁酸) | 10.229 | ESI+ | 204.20 | 186.20*, 29.90 | -10, -28 |
30 | atrazine (莠去津) | 10.556 | ESI+ | 406.10 | 174.05*, 96.05 | -17, -25 |
31 | forchlorfenuron (氯吡脲) | 10.595 | ESI+ | 248.05 | 129.05*, 93.05 | -17, -34 |
32 | metalaxyl-M (精甲霜灵) | 10.614 | ESI+ | 280.10 | 220.15*, 48.10 | -13, -10 |
33 | metalaxyl (甲霜灵) | 10.619 | ESI+ | 280.10 | 220.15*, 92.15 | -13, -18 |
34 | 2,4-dichlorophenoxyacetic acid (2,4-滴) | 10.669 | ESI- | 409.00 | 160.85*, 25.00 | 14, 29 |
35 | azoxystrobin (嘧菌酯) | 10.826 | ESI+ | 404.10 | 372.05*, 29.00 | -14, -31 |
36 | paclobutrazol (多效唑) | 11.064 | ESI+ | 294.10 | 70.05*, 125.05 | -40, -40 |
37 | triazophos (三唑磷) | 11.152 | ESI+ | 314.05 | 162.15*, 19.15 | -19, -35 |
38 | isazophos (氯唑磷) | 11.161 | ESI+ | 314.10 | 162.10*, 20.10 | -16, -27 |
39 | flusilazole (氟硅唑) | 11.394 | ESI+ | 316.10 | 247.10*, 65.10 | -18, -29 |
40 | pyraclostrobin (吡唑醚菌酯) | 11.635 | ESI+ | 388.10 | 194.05*, 63.05 | -30, -32 |
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
---|---|---|---|---|---|
Chlormequat | y=1.27×103x-5.36×102 | 2-200 | 0.9966 | 1.5 | 4.5 |
Ronidazole | y=1.82×104x-9.28×103 | 2-200 | 0.9987 | 0.1 | 0.3 |
Metronidazole | y=1.28×104x+4.55×103 | 2-200 | 0.9998 | 0.5 | 1.5 |
Pymetrozine | y=2.98×104x-1.13×105 | 2-200 | 0.9929 | 0.5 | 1.5 |
Dimetridazole | y=3.14×104x-1.22×104 | 2-200 | 0.9997 | 0.2 | 0.6 |
Methomyl | y=1.43×104x-3.36×104 | 2-200 | 0.9914 | 0.2 | 0.6 |
Carbendazim | y=5.18×104x+3.92×104 | 2-200 | 0.9998 | 0.2 | 0.6 |
Enoxacin | y=2.01×104x-1.33×104 | 2-200 | 0.9919 | 1.0 | 3.0 |
Levofloxacin | y=2.07×104x-6.38×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
pefloxacin mesylate | y=1.07×104x-2.77×104 | 2-200 | 0.9959 | 1.0 | 3.0 |
Norfloxacin | y=2.86×104x-1.09×104 | 2-200 | 0.9977 | 0.5 | 1.5 |
Ciprofloxacin | y=1.01×104x+1.21×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
Enrofloxacin | y=1.45×104x-6.98×104 | 2-200 | 0.9932 | 1.0 | 3.0 |
Thiabendazole | y=1.26×104x-1.20×104 | 2-200 | 0.9976 | 0.5 | 1.5 |
Lomefloxacin | y=3.72×104x-1.31×103 | 2-200 | 0.9917 | 0.5 | 1.5 |
Chlorpyrifos | y=2.17×104x-4.32×104 | 2-200 | 0.9903 | 0.5 | 1.5 |
Sarafloxacin | y=2.25×104x-7.64×104 | 2-200 | 0.9953 | 0.5 | 1.5 |
Imidacloprid | y=3.84×103x-1.55×104 | 2-200 | 0.9908 | 1.0 | 3.0 |
Sparfloxacin | y=9.99×103x-4.35×104 | 2-200 | 0.9906 | 0.5 | 1.5 |
Acetamiprid | y=1.18×104x-1.79×104 | 2-200 | 0.9948 | 0.5 | 1.5 |
Gibberellic acid | y=5.95×104x-2.08×103 | 2-200 | 0.9914 | 3.0 | 9.0 |
4-Fluorophenoxyacetic acid | y=6.08×103x-3.00×103 | 2-200 | 0.9989 | 1.5 | 4.5 |
Chloramphenicol | y=8.61×102x+1.86×103 | 2-200 | 0.9970 | 3.0 | 9.0 |
3-Indolylacetic acid | y=7.02×103x+1.76×103 | 2-200 | 0.9961 | 2.0 | 6.0 |
N6-(δ2-Isopentenyl)-adenine | y=3.27×102x-3.65×102 | 2-200 | 0.9967 | 3.0 | 9.0 |
6-Benzylaminopurine | y=3.97×102x-2.74×103 | 2-200 | 0.9945 | 3.0 | 9.0 |
4-Chlorophenoxyacetic acid | y=2.78×103x-2.33×103 | 2-200 | 0.9995 | 3.0 | 9.0 |
Thidiazuron | y=5.69×104x-2.10×104 | 2-200 | 0.9996 | 0.5 | 1.5 |
3-Indolebutyric acid | y=4.55×103x-4.29×103 | 2-200 | 0.9967 | 2.0 | 6.0 |
Atrazine | y=2.23×104x-7.41×104 | 2-200 | 0.9956 | 0.2 | 0.6 |
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
Forchlorfenuron | y=1.83×105x-3.65×105 | 2-200 | 0.9977 | 0.1 | 0.3 |
Metalaxyl-M | y=4.74×104x+1.29×105 | 2-200 | 0.9981 | 0.2 | 0.6 |
Metalaxyl | y=2.84×104x+9.92×104 | 2-200 | 0.9966 | 0.2 | 0.6 |
2,4-Dichlorophenoxyacetic acid | y=8.84×103x-3.59×103 | 2-200 | 0.9995 | 2.0 | 6.0 |
Azoxystrobin | y=5.32×104x+1.19×104 | 2-200 | 0.9992 | 0.2 | 0.6 |
Paclobutrazol | y=2.02×105x-3.79×102 | 2-200 | 0.9986 | 0.1 | 0.3 |
Triazophos | y=6.95×104x+1.02×105 | 2-200 | 0.9983 | 0.1 | 0.3 |
Isazophos | y=6.66×104x+1.08×105 | 2-200 | 0.9966 | 0.1 | 0.3 |
Flusilazole | y=3.28×104x-2.57×104 | 2-200 | 0.9994 | 1.0 | 3.0 |
Pyraclostrobin | y=8.67×104x+5.62×105 | 2-200 | 0.9979 | 0.5 | 1.5 |
Table 2 Linear equations, linear ranges, correlation coefficients (r2), LODs and LOQs of the 40 compounds
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
---|---|---|---|---|---|
Chlormequat | y=1.27×103x-5.36×102 | 2-200 | 0.9966 | 1.5 | 4.5 |
Ronidazole | y=1.82×104x-9.28×103 | 2-200 | 0.9987 | 0.1 | 0.3 |
Metronidazole | y=1.28×104x+4.55×103 | 2-200 | 0.9998 | 0.5 | 1.5 |
Pymetrozine | y=2.98×104x-1.13×105 | 2-200 | 0.9929 | 0.5 | 1.5 |
Dimetridazole | y=3.14×104x-1.22×104 | 2-200 | 0.9997 | 0.2 | 0.6 |
Methomyl | y=1.43×104x-3.36×104 | 2-200 | 0.9914 | 0.2 | 0.6 |
Carbendazim | y=5.18×104x+3.92×104 | 2-200 | 0.9998 | 0.2 | 0.6 |
Enoxacin | y=2.01×104x-1.33×104 | 2-200 | 0.9919 | 1.0 | 3.0 |
Levofloxacin | y=2.07×104x-6.38×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
pefloxacin mesylate | y=1.07×104x-2.77×104 | 2-200 | 0.9959 | 1.0 | 3.0 |
Norfloxacin | y=2.86×104x-1.09×104 | 2-200 | 0.9977 | 0.5 | 1.5 |
Ciprofloxacin | y=1.01×104x+1.21×104 | 2-200 | 0.9939 | 1.0 | 3.0 |
Enrofloxacin | y=1.45×104x-6.98×104 | 2-200 | 0.9932 | 1.0 | 3.0 |
Thiabendazole | y=1.26×104x-1.20×104 | 2-200 | 0.9976 | 0.5 | 1.5 |
Lomefloxacin | y=3.72×104x-1.31×103 | 2-200 | 0.9917 | 0.5 | 1.5 |
Chlorpyrifos | y=2.17×104x-4.32×104 | 2-200 | 0.9903 | 0.5 | 1.5 |
Sarafloxacin | y=2.25×104x-7.64×104 | 2-200 | 0.9953 | 0.5 | 1.5 |
Imidacloprid | y=3.84×103x-1.55×104 | 2-200 | 0.9908 | 1.0 | 3.0 |
Sparfloxacin | y=9.99×103x-4.35×104 | 2-200 | 0.9906 | 0.5 | 1.5 |
Acetamiprid | y=1.18×104x-1.79×104 | 2-200 | 0.9948 | 0.5 | 1.5 |
Gibberellic acid | y=5.95×104x-2.08×103 | 2-200 | 0.9914 | 3.0 | 9.0 |
4-Fluorophenoxyacetic acid | y=6.08×103x-3.00×103 | 2-200 | 0.9989 | 1.5 | 4.5 |
Chloramphenicol | y=8.61×102x+1.86×103 | 2-200 | 0.9970 | 3.0 | 9.0 |
3-Indolylacetic acid | y=7.02×103x+1.76×103 | 2-200 | 0.9961 | 2.0 | 6.0 |
N6-(δ2-Isopentenyl)-adenine | y=3.27×102x-3.65×102 | 2-200 | 0.9967 | 3.0 | 9.0 |
6-Benzylaminopurine | y=3.97×102x-2.74×103 | 2-200 | 0.9945 | 3.0 | 9.0 |
4-Chlorophenoxyacetic acid | y=2.78×103x-2.33×103 | 2-200 | 0.9995 | 3.0 | 9.0 |
Thidiazuron | y=5.69×104x-2.10×104 | 2-200 | 0.9996 | 0.5 | 1.5 |
3-Indolebutyric acid | y=4.55×103x-4.29×103 | 2-200 | 0.9967 | 2.0 | 6.0 |
Atrazine | y=2.23×104x-7.41×104 | 2-200 | 0.9956 | 0.2 | 0.6 |
Compound | Linear equation | Linear range/(μg/L) | r2 | LOD/(μg/kg) | LOQ/(μg/kg) |
Forchlorfenuron | y=1.83×105x-3.65×105 | 2-200 | 0.9977 | 0.1 | 0.3 |
Metalaxyl-M | y=4.74×104x+1.29×105 | 2-200 | 0.9981 | 0.2 | 0.6 |
Metalaxyl | y=2.84×104x+9.92×104 | 2-200 | 0.9966 | 0.2 | 0.6 |
2,4-Dichlorophenoxyacetic acid | y=8.84×103x-3.59×103 | 2-200 | 0.9995 | 2.0 | 6.0 |
Azoxystrobin | y=5.32×104x+1.19×104 | 2-200 | 0.9992 | 0.2 | 0.6 |
Paclobutrazol | y=2.02×105x-3.79×102 | 2-200 | 0.9986 | 0.1 | 0.3 |
Triazophos | y=6.95×104x+1.02×105 | 2-200 | 0.9983 | 0.1 | 0.3 |
Isazophos | y=6.66×104x+1.08×105 | 2-200 | 0.9966 | 0.1 | 0.3 |
Flusilazole | y=3.28×104x-2.57×104 | 2-200 | 0.9994 | 1.0 | 3.0 |
Pyraclostrobin | y=8.67×104x+5.62×105 | 2-200 | 0.9979 | 0.5 | 1.5 |
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
---|---|---|---|---|---|---|---|---|
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Chlormequat | 83.4 | 6.9 | 86.1 | 5.2 | 93.6 | 2.8 | ||
Ronidazole | 111.2 | 4.3 | 93.2 | 2.4 | 96.2 | 3.7 | ||
Metronidazole | 88.2 | 5.3 | 85.7 | 6.5 | 91.0 | 5.7 | ||
Pymetrozine | 102.4 | 6.9 | 82.1 | 5.1 | 84.5 | 6.5 | ||
Dimetridazole | 108.4 | 2.1 | 89.6 | 3.9 | 92.6 | 2.2 | ||
Methomyl | 82.7 | 8.7 | 89.4 | 4.9 | 85.4 | 5.1 | ||
Carbendazim | 84.3 | 7.5 | 97.6 | 4.7 | 94.1 | 8.0 | ||
Enoxacin | 82.6 | 1.8 | 95.6 | 3.0 | 101.7 | 4.5 | ||
Levofloxacin | 102.1 | 7.6 | 106.5 | 7.1 | 93.0 | 5.4 | ||
pefloxacin mesylate | 90.3 | 7.1 | 101.5 | 5.9 | 92.8 | 4.1 | ||
Norfloxacin | 84.2 | 5.9 | 86.7 | 4.6 | 88.6 | 4.7 | ||
Ciprofloxacin | 99.5 | 8.3 | 102.2 | 7.2 | 96.4 | 4.3 | ||
Enrofloxacin | 104.7 | 5.3 | 100.9 | 4.2 | 101.6 | 3.8 | ||
Thiabendazole | 85.4 | 9.0 | 82.9 | 6.3 | 82.6 | 4.4 | ||
Lomefloxacin | 97.9 | 6.2 | 105.5 | 6.1 | 99.2 | 2.9 | ||
Chlorpyrifos | 112.6 | 9.7 | 113.1 | 6.3 | 107.4 | 4.1 | ||
Sarafloxacin | 108.4 | 4.4 | 105.2 | 3.9 | 102.6 | 3.7 | ||
Imidacloprid | 80.0 | 7.6 | 84.4 | 6.2 | 85.1 | 5.9 | ||
Sparfloxacin | 106.6 | 5.3 | 98.4 | 3.6 | 102.5 | 5.4 | ||
Acetamiprid | 105.3 | 3.8 | 111.6 | 3.2 | 115.3 | 4.2 | ||
Gibberellic acid | 77.4 | 8.2 | 81.6 | 1.7 | 82.1 | 5.7 | ||
4-Fluorophenoxyacetic acid | 98.6 | 7.2 | 93.6 | 4.8 | 91.9 | 3.3 | ||
Chloramphenicol | 78.8 | 4.0 | 85.8 | 5.1 | 85.4 | 5.9 | ||
3-Indolylacetic acid | 89.9 | 3.1 | 86.5 | 3.4 | 97.7 | 6.3 | ||
N6-(δ2-Isopentenyl)-adenine | 92.3 | 1.6 | 87.2 | 6.2 | 96.8 | 4.0 | ||
6-Benzylaminopurine | 102.4 | 6.4 | 94.3 | 5.9 | 95.6 | 5.2 | ||
4-Chlorophenoxyacetic acid | 111.3 | 8.9 | 108.4 | 5.3 | 106.8 | 5.7 | ||
Thidiazuron | 94.7 | 1.9 | 95.5 | 4.6 | 92.7 | 2.4 | ||
3-Indolebutyric acid | 78.5 | 6.2 | 90.3 | 3.6 | 86.4 | 3.5 | ||
Atrazine | 94.6 | 3.8 | 89.0 | 6.4 | 86.9 | 4.6 | ||
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Forchlorfenuron | 103.4 | 5.3 | 108.2 | 4.2 | 105.7 | 2.7 | ||
Metalaxyl-M | 112.4 | 4.7 | 98.8 | 2.7 | 106.4 | 4.6 | ||
Metalaxyl | 97.4 | 3.0 | 108.5 | 1.7 | 102.1 | 3.2 | ||
2,4-Dichlorophenoxyacetic acid | 85.5 | 8.3 | 83.2 | 8.0 | 87.5 | 6.6 | ||
Azoxystrobin | 91.6 | 3.4 | 87.3 | 5.7 | 84.2 | 5.9 | ||
Paclobutrazol | 112.6 | 2.2 | 103.5 | 6.1 | 107.6 | 3.6 | ||
Triazophos | 82.1 | 9.1 | 84.3 | 7.4 | 88.6 | 5.5 | ||
Isazophos | 91.6 | 5.5 | 83.6 | 3.8 | 84.3 | 1.9 | ||
Flusilazole | 82.1 | 2.1 | 88.3 | 4.4 | 85.7 | 1.3 | ||
Pyraclostrobin | 116.4 | 5.9 | 107.2 | 4.6 | 108.7 | 4.8 |
Table 3 Recoveries and precisions of the 40 compounds (n=6)
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
---|---|---|---|---|---|---|---|---|
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Chlormequat | 83.4 | 6.9 | 86.1 | 5.2 | 93.6 | 2.8 | ||
Ronidazole | 111.2 | 4.3 | 93.2 | 2.4 | 96.2 | 3.7 | ||
Metronidazole | 88.2 | 5.3 | 85.7 | 6.5 | 91.0 | 5.7 | ||
Pymetrozine | 102.4 | 6.9 | 82.1 | 5.1 | 84.5 | 6.5 | ||
Dimetridazole | 108.4 | 2.1 | 89.6 | 3.9 | 92.6 | 2.2 | ||
Methomyl | 82.7 | 8.7 | 89.4 | 4.9 | 85.4 | 5.1 | ||
Carbendazim | 84.3 | 7.5 | 97.6 | 4.7 | 94.1 | 8.0 | ||
Enoxacin | 82.6 | 1.8 | 95.6 | 3.0 | 101.7 | 4.5 | ||
Levofloxacin | 102.1 | 7.6 | 106.5 | 7.1 | 93.0 | 5.4 | ||
pefloxacin mesylate | 90.3 | 7.1 | 101.5 | 5.9 | 92.8 | 4.1 | ||
Norfloxacin | 84.2 | 5.9 | 86.7 | 4.6 | 88.6 | 4.7 | ||
Ciprofloxacin | 99.5 | 8.3 | 102.2 | 7.2 | 96.4 | 4.3 | ||
Enrofloxacin | 104.7 | 5.3 | 100.9 | 4.2 | 101.6 | 3.8 | ||
Thiabendazole | 85.4 | 9.0 | 82.9 | 6.3 | 82.6 | 4.4 | ||
Lomefloxacin | 97.9 | 6.2 | 105.5 | 6.1 | 99.2 | 2.9 | ||
Chlorpyrifos | 112.6 | 9.7 | 113.1 | 6.3 | 107.4 | 4.1 | ||
Sarafloxacin | 108.4 | 4.4 | 105.2 | 3.9 | 102.6 | 3.7 | ||
Imidacloprid | 80.0 | 7.6 | 84.4 | 6.2 | 85.1 | 5.9 | ||
Sparfloxacin | 106.6 | 5.3 | 98.4 | 3.6 | 102.5 | 5.4 | ||
Acetamiprid | 105.3 | 3.8 | 111.6 | 3.2 | 115.3 | 4.2 | ||
Gibberellic acid | 77.4 | 8.2 | 81.6 | 1.7 | 82.1 | 5.7 | ||
4-Fluorophenoxyacetic acid | 98.6 | 7.2 | 93.6 | 4.8 | 91.9 | 3.3 | ||
Chloramphenicol | 78.8 | 4.0 | 85.8 | 5.1 | 85.4 | 5.9 | ||
3-Indolylacetic acid | 89.9 | 3.1 | 86.5 | 3.4 | 97.7 | 6.3 | ||
N6-(δ2-Isopentenyl)-adenine | 92.3 | 1.6 | 87.2 | 6.2 | 96.8 | 4.0 | ||
6-Benzylaminopurine | 102.4 | 6.4 | 94.3 | 5.9 | 95.6 | 5.2 | ||
4-Chlorophenoxyacetic acid | 111.3 | 8.9 | 108.4 | 5.3 | 106.8 | 5.7 | ||
Thidiazuron | 94.7 | 1.9 | 95.5 | 4.6 | 92.7 | 2.4 | ||
3-Indolebutyric acid | 78.5 | 6.2 | 90.3 | 3.6 | 86.4 | 3.5 | ||
Atrazine | 94.6 | 3.8 | 89.0 | 6.4 | 86.9 | 4.6 | ||
Compound | 5 μg/kg | 10 μg/kg | 50 μg/kg | |||||
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Forchlorfenuron | 103.4 | 5.3 | 108.2 | 4.2 | 105.7 | 2.7 | ||
Metalaxyl-M | 112.4 | 4.7 | 98.8 | 2.7 | 106.4 | 4.6 | ||
Metalaxyl | 97.4 | 3.0 | 108.5 | 1.7 | 102.1 | 3.2 | ||
2,4-Dichlorophenoxyacetic acid | 85.5 | 8.3 | 83.2 | 8.0 | 87.5 | 6.6 | ||
Azoxystrobin | 91.6 | 3.4 | 87.3 | 5.7 | 84.2 | 5.9 | ||
Paclobutrazol | 112.6 | 2.2 | 103.5 | 6.1 | 107.6 | 3.6 | ||
Triazophos | 82.1 | 9.1 | 84.3 | 7.4 | 88.6 | 5.5 | ||
Isazophos | 91.6 | 5.5 | 83.6 | 3.8 | 84.3 | 1.9 | ||
Flusilazole | 82.1 | 2.1 | 88.3 | 4.4 | 85.7 | 1.3 | ||
Pyraclostrobin | 116.4 | 5.9 | 107.2 | 4.6 | 108.7 | 4.8 |
Compound | Contents/(μg/kg) | |
---|---|---|
This method | Standard method | |
4-Chlorophenoxyacetic acid | 37.5-52.4 | 34.2-343.5 |
6-Benzylaminopurine | 32.4-273.1 | 29.3-279.4 |
Carbendazim | 28.8-38.7 | - |
2,4-Dichlorophenoxyacetic acid | 16.1-20.2 | 14.1-18.3 |
Gibberellic acid | 19.9 | 22.1 |
Enrofloxacin | 13.6 | 15.3 |
Table 4 Test results of real samples
Compound | Contents/(μg/kg) | |
---|---|---|
This method | Standard method | |
4-Chlorophenoxyacetic acid | 37.5-52.4 | 34.2-343.5 |
6-Benzylaminopurine | 32.4-273.1 | 29.3-279.4 |
Carbendazim | 28.8-38.7 | - |
2,4-Dichlorophenoxyacetic acid | 16.1-20.2 | 14.1-18.3 |
Gibberellic acid | 19.9 | 22.1 |
Enrofloxacin | 13.6 | 15.3 |
Compound | LODs/(μg/kg) | |
---|---|---|
Reference | This work | |
Chlormequat | 5[ | 0.2 |
Carbendazim | 45[ | 0.2 |
Ronidazole | 0.4[ | 0.1 |
Dimethylnidazole | 0.5[ | 0.2 |
Carbendazim | 3.7[ | 0.2 |
Enoxacin | 2[ | 1.0 |
Levofloxacin | 2[ | 1.0 |
pefloxacin mesylate | 2[ | 1.0 |
Norfloxacin | 64[ | 0.5 |
Ciprofloxacin | 2[ | 1.0 |
Enrofloxacin | 2[ | 1.0 |
Thiabendazole | 2.1[ | 0.5 |
Lomefloxacin | 2[ | 0.5 |
Sarafloxacin | 2[ | 0.5 |
Sparfloxacin | 2[ | 0.5 |
Gibberellic acid | 6.0[ | 3.0 |
4-Fluorophenoxyacetic acid | 10[ | 1.5 |
Chloramphenicol | 10[ | 2.0 |
3-Indolylacetic acid | 72[ | 3.0 |
N6-(δ2-Isopentenyl)-adenine | 10[ | 3.0 |
6-Benzylaminopurine | 3.8[ | 3.0 |
4-Chlorophenoxyacetic acid | 5[ | 3.0 |
Thidiazuron | 10[ | 0.2 |
3-Indolebutyric acid | 10[ | 2.0 |
Atrazine | 1[ | 0.2 |
Forchlorfenuron | 0.26[ | 0.1 |
2,4-Dichlorophenoxyacetic acid | 1[ | 2.0 |
Paclobutrazol | 0.6[ | 0.1 |
Table 5 Comparison of the proposed method with references
Compound | LODs/(μg/kg) | |
---|---|---|
Reference | This work | |
Chlormequat | 5[ | 0.2 |
Carbendazim | 45[ | 0.2 |
Ronidazole | 0.4[ | 0.1 |
Dimethylnidazole | 0.5[ | 0.2 |
Carbendazim | 3.7[ | 0.2 |
Enoxacin | 2[ | 1.0 |
Levofloxacin | 2[ | 1.0 |
pefloxacin mesylate | 2[ | 1.0 |
Norfloxacin | 64[ | 0.5 |
Ciprofloxacin | 2[ | 1.0 |
Enrofloxacin | 2[ | 1.0 |
Thiabendazole | 2.1[ | 0.5 |
Lomefloxacin | 2[ | 0.5 |
Sarafloxacin | 2[ | 0.5 |
Sparfloxacin | 2[ | 0.5 |
Gibberellic acid | 6.0[ | 3.0 |
4-Fluorophenoxyacetic acid | 10[ | 1.5 |
Chloramphenicol | 10[ | 2.0 |
3-Indolylacetic acid | 72[ | 3.0 |
N6-(δ2-Isopentenyl)-adenine | 10[ | 3.0 |
6-Benzylaminopurine | 3.8[ | 3.0 |
4-Chlorophenoxyacetic acid | 5[ | 3.0 |
Thidiazuron | 10[ | 0.2 |
3-Indolebutyric acid | 10[ | 2.0 |
Atrazine | 1[ | 0.2 |
Forchlorfenuron | 0.26[ | 0.1 |
2,4-Dichlorophenoxyacetic acid | 1[ | 2.0 |
Paclobutrazol | 0.6[ | 0.1 |
|
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 446
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 227
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||